A detailed history of Pnc Financial Services Group, Inc. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 131 shares of ALXO stock, worth $221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
131
Previous 131 -0.0%
Holding current value
$221
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$4.81 - $15.38 $149 - $476
31 Added 31.0%
131 $1,000
Q3 2023

Nov 13, 2023

SELL
$4.19 - $7.35 $3,486 - $6,115
-832 Reduced 89.27%
100 $0
Q1 2023

May 15, 2023

BUY
$4.52 - $11.71 $3,760 - $9,742
832 Added 832.0%
932 $4,000
Q1 2022

May 12, 2022

SELL
$13.65 - $22.06 $27,300 - $44,120
-2,000 Reduced 95.24%
100 $1,000
Q4 2021

Feb 11, 2022

BUY
$21.49 - $74.4 $42,980 - $148,800
2,000 Added 2000.0%
2,100 $45,000
Q3 2021

Nov 05, 2021

BUY
$52.51 - $80.91 $5,251 - $8,091
100 New
100 $7,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $68.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.